Trials / Terminated
TerminatedNCT01109966
An Elimination Diet Using a New Amino Acid Based Formula: Immunological and Clinical Effects in Cow's Milk Allergy
A Prospective, Double Blind Randomised Controlled Trial to Evaluate the Immunological Benefits and Clinical Effects of an Elimination Diet Using an Amino Acid Based Formula (AAF)
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 34 (actual)
- Sponsor
- Nutricia Research · Industry
- Sex
- All
- Age
- 8 Months
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate whether a new version of an amino acid based formula improves tolerance to milk in cow's milk allergic infants/young children.
Detailed description
Infants with CMA cannot tolerate proteins contained in milk, although they are able to tolerate amino acids which are the 'building blocks' of proteins. Unlike standard infant formulas which are made from milk proteins, amino acid formulas (AAF) are made from nonallergenic aminoacids plus all the other nutrients required to support growth and development.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Special Medical Food | Comparison between a standard amino acid based formula and a new amino acid based formula. Subjects with CMA will take their randomised formula for 12 months. Following completion of the intervention (12 months), subjects will transfer to an age appropriate formula and be followed-up at 24 and 36 months. Infants should typically consume the following amounts of formula during the study \> 500mls/day up to 12 months of age \> 400mls/day between 12 and 18 months of age \> 300mls/day over 18 months of age. |
| OTHER | Special Medical Food | Comparison between a standard amino acid based formula and a new amino acid based formula. Subjects with CMA will take their randomised formula for 12 months. Following completion of the intervention (12 months), subjects will transfer to an age appropriate formula and be followed-up at 24 and 36 months. Infants should typically consume the following amounts of formula during the study \> 500mls/day up to 12 months of age \> 400mls/day between 12 and 18 months of age \> 300mls/day over 18 months of age. |
Timeline
- Start date
- 2010-06-01
- Primary completion
- 2012-10-01
- Completion
- 2012-10-01
- First posted
- 2010-04-23
- Last updated
- 2017-05-08
Locations
7 sites across 3 countries: France, Germany, United Kingdom
Source: ClinicalTrials.gov record NCT01109966. Inclusion in this directory is not an endorsement.